Annual CFO
-$88.80 M
+$11.77 M+11.70%
December 31, 2023
Summary
- As of February 7, 2025, KRYS annual cash flow from operations is -$88.80 million, with the most recent change of +$11.77 million (+11.70%) on December 31, 2023.
- During the last 3 years, KRYS annual CFO has fallen by -$62.72 million (-240.47%).
- KRYS annual CFO is now -6673.76% below its all-time high of -$1.31 million, reached on December 31, 2016.
Performance
KRYS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$58.86 M
+$63.02 M+1512.12%
September 30, 2024
Summary
- As of February 7, 2025, KRYS quarterly cash flow from operations is $58.86 million, with the most recent change of +$63.02 million (+1512.12%) on September 30, 2024.
- Over the past year, KRYS quarterly CFO has increased by +$80.08 million (+377.29%).
- KRYS quarterly CFO is now at all-time high.
Performance
KRYS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$63.34 M
+$80.08 M+478.45%
September 30, 2024
Summary
- As of February 7, 2025, KRYS TTM cash flow from operations is $63.34 million, with the most recent change of +$80.08 million (+478.45%) on September 30, 2024.
- Over the past year, KRYS TTM CFO has increased by +$167.25 million (+160.97%).
- KRYS TTM CFO is now at all-time high.
Performance
KRYS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KRYS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.7% | +377.3% | +161.0% |
| 3 y3 years | -240.5% | +363.6% | +163.0% |
| 5 y5 years | -840.2% | +363.6% | +163.0% |
KRYS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.3% | +11.7% | at high | +236.7% | at high | +156.9% |
| 5 y | 5-year | -375.1% | +11.7% | at high | +236.7% | at high | +156.9% |
| alltime | all time | -6673.8% | +11.7% | at high | +236.7% | at high | +156.9% |
Krystal Biotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $58.86 M(-1512.1%) | $63.34 M(-478.5%) |
| Jun 2024 | - | -$4.17 M(-126.2%) | -$16.74 M(-64.2%) |
| Mar 2024 | - | $15.89 M(-319.7%) | -$46.76 M(-47.3%) |
| Dec 2023 | -$88.80 M(-11.7%) | -$7.23 M(-65.9%) | -$88.80 M(-14.5%) |
| Sep 2023 | - | -$21.23 M(-37.9%) | -$103.90 M(+1.5%) |
| Jun 2023 | - | -$34.19 M(+30.7%) | -$102.36 M(-8.0%) |
| Mar 2023 | - | -$26.16 M(+17.1%) | -$111.23 M(+10.6%) |
| Dec 2022 | -$100.57 M(+109.8%) | -$22.33 M(+13.4%) | -$100.57 M(+1.4%) |
| Sep 2022 | - | -$19.69 M(-54.3%) | -$99.14 M(+14.3%) |
| Jun 2022 | - | -$43.06 M(+177.9%) | -$86.71 M(+61.2%) |
| Mar 2022 | - | -$15.49 M(-25.9%) | -$53.78 M(+12.2%) |
| Dec 2021 | -$47.94 M(+83.8%) | -$20.90 M(+188.1%) | -$47.94 M(+36.7%) |
| Sep 2021 | - | -$7.25 M(-28.4%) | -$35.06 M(+1.4%) |
| Jun 2021 | - | -$10.13 M(+4.9%) | -$34.59 M(+17.2%) |
| Mar 2021 | - | -$9.65 M(+20.3%) | -$29.51 M(+13.1%) |
| Dec 2020 | -$26.08 M | -$8.02 M(+18.4%) | -$26.08 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$6.78 M(+34.1%) | -$25.06 M(+11.1%) |
| Jun 2020 | - | -$5.05 M(-18.8%) | -$22.55 M(+3.9%) |
| Mar 2020 | - | -$6.23 M(-11.0%) | -$21.70 M(+16.1%) |
| Dec 2019 | -$18.69 M(+97.9%) | -$7.00 M(+64.1%) | -$18.69 M(+22.9%) |
| Sep 2019 | - | -$4.27 M(+1.4%) | -$15.21 M(+18.1%) |
| Jun 2019 | - | -$4.21 M(+30.9%) | -$12.88 M(+25.2%) |
| Mar 2019 | - | -$3.21 M(-8.6%) | -$10.29 M(+9.0%) |
| Dec 2018 | -$9.45 M(+142.8%) | -$3.52 M(+81.3%) | -$9.45 M(+17.3%) |
| Sep 2018 | - | -$1.94 M(+19.9%) | -$8.05 M(+11.7%) |
| Jun 2018 | - | -$1.62 M(-31.7%) | -$7.21 M(+20.2%) |
| Mar 2018 | - | -$2.37 M(+11.4%) | -$6.00 M(+54.3%) |
| Dec 2017 | -$3.89 M(+196.7%) | -$2.13 M(+93.7%) | -$3.89 M(+120.6%) |
| Sep 2017 | - | -$1.10 M(+169.1%) | -$1.76 M(+165.1%) |
| Jun 2017 | - | -$408.00 K(+58.8%) | -$665.00 K(+158.8%) |
| Mar 2017 | - | -$257.00 K | -$257.00 K |
| Dec 2016 | -$1.31 M | - | - |
FAQ
- What is Krystal Biotech annual cash flow from operations?
- What is the all time high annual CFO for Krystal Biotech?
- What is Krystal Biotech annual CFO year-on-year change?
- What is Krystal Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for Krystal Biotech?
- What is Krystal Biotech quarterly CFO year-on-year change?
- What is Krystal Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for Krystal Biotech?
- What is Krystal Biotech TTM CFO year-on-year change?
What is Krystal Biotech annual cash flow from operations?
The current annual CFO of KRYS is -$88.80 M
What is the all time high annual CFO for Krystal Biotech?
Krystal Biotech all-time high annual cash flow from operations is -$1.31 M
What is Krystal Biotech annual CFO year-on-year change?
Over the past year, KRYS annual cash flow from operations has changed by +$11.77 M (+11.70%)
What is Krystal Biotech quarterly cash flow from operations?
The current quarterly CFO of KRYS is $58.86 M
What is the all time high quarterly CFO for Krystal Biotech?
Krystal Biotech all-time high quarterly cash flow from operations is $58.86 M
What is Krystal Biotech quarterly CFO year-on-year change?
Over the past year, KRYS quarterly cash flow from operations has changed by +$80.08 M (+377.29%)
What is Krystal Biotech TTM cash flow from operations?
The current TTM CFO of KRYS is $63.34 M
What is the all time high TTM CFO for Krystal Biotech?
Krystal Biotech all-time high TTM cash flow from operations is $63.34 M
What is Krystal Biotech TTM CFO year-on-year change?
Over the past year, KRYS TTM cash flow from operations has changed by +$167.25 M (+160.97%)